Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97971709 | 9797170 | 9 | F | 20131111 | 20160831 | 20140106 | 20160906 | EXP | PHHY2013IL130164 | NOVARTIS | 78.37 | YR | M | Y | 85.00000 | KG | 20160906 | CN | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97971709 | 9797170 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, EVERY FOUR WEEK (Q4W) | U | SO053, SO309 | 21008 | 40 | MG | /month | |||||
| 97971709 | 9797170 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO | U | 0246, S0252, SO046, SO267/SO047/SO | 21008 | 40 | MG | /month | |||||
| 97971709 | 9797170 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, QMO | U | S0324 | 21008 | 60 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97971709 | 9797170 | 1 | Carcinoid tumour |
| 97971709 | 9797170 | 2 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97971709 | 9797170 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97971709 | 9797170 | Abdominal pain | |
| 97971709 | 9797170 | Anal incontinence | |
| 97971709 | 9797170 | Asthenia | |
| 97971709 | 9797170 | Diarrhoea | |
| 97971709 | 9797170 | Erythema | |
| 97971709 | 9797170 | Fall | |
| 97971709 | 9797170 | Feeling abnormal | |
| 97971709 | 9797170 | Flushing | |
| 97971709 | 9797170 | Heart rate decreased | |
| 97971709 | 9797170 | Hyperhidrosis | |
| 97971709 | 9797170 | Hypoglycaemia | |
| 97971709 | 9797170 | Hypotension | |
| 97971709 | 9797170 | Loss of consciousness | |
| 97971709 | 9797170 | Nausea | |
| 97971709 | 9797170 | Pruritus | |
| 97971709 | 9797170 | Pruritus generalised | |
| 97971709 | 9797170 | Rash | |
| 97971709 | 9797170 | Rash generalised | |
| 97971709 | 9797170 | Sensory loss | |
| 97971709 | 9797170 | Skin burning sensation | |
| 97971709 | 9797170 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 97971709 | 9797170 | 1 | 20130603 | 0 | ||
| 97971709 | 9797170 | 3 | 20160831 | 0 |